Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7512538 | International Journal of Drug Policy | 2016 | 32 Pages |
Abstract
Expert advice was critical in the process of re-medicalization. Initially, discourse occurred in the closed expert committees of the ACMD. The drug problem had been framed under the criminal justice system but as the limitations of this were revealed, and there was continuing uncertainty over cannabis' impact, new approaches to cannabis were sought. It was this combination of more relaxed attitudes towards cannabis, research incentives, as well as a developing desire to draw medical needs away from discussion of drug control that was to allow re-medicalization to develop.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Suzanne L. Taylor,